MD, Boston University School of Medicine
favorite icon BIDMC

Risk Factors for Cognitive Change in Parkinson's Disease from the Framingham Study
05/02/2014 - 04/30/2016 (Co-Investigator)
PI: Rhoda Au, PhD
National Parkinson Foundation Inc

Mortality in PD: The PEACE Consortium
09/01/2014 - 08/31/2015 (PI)
American Parkinson Disease Association, Inc.

Supplemental Analyses of Tetra HD and the Open Label Study to Address Unanswered Questions Regarding the Impact of Concomitant Depression and Antidepressant Use, Value, of Tetrabenazine
02/01/2011 - 01/31/2012 (Subcontract PI)
University of Rochester Lundbeck, Inc

Cooperative Huntington's Observational Research Trial (COHORT)
07/01/2005 - 06/30/2011 (PI)
HP Therapeutics Foundation, Inc.

PARS- Parkinson's Associated Risk Study
04/04/2007 - 04/03/2011 (PI)
The Institute for Neurodegenerative Disorders

Fox Investigation for New Discovery of Biomarkers (BioFIND)
11/26/2013 - 12/31/2015 (PI)
Michael J. Fox Foundation

Protocol Number: SD-809-C-09. A Randomized, double-blinded, placebo-controlled trial to evaluate the
04/16/2013 - 12/31/2015 (PI)
Huntington Study Group, Ltd. Auspex Pharmaceutica

An Interdisciplinary Approach to Accommodate Fine Motor Control Disorders
10/01/2011 - 09/30/2014 (PI)
Northeastern University National Science Fdn

Coenzyme Q10 in Huntington's Disease
12/01/2007 - 07/31/2014 (PI)
Mass General Hosp NIH-NINDS
5U01 NS052592-05

Ethics of Sham Surgery Controls to test Novel PD interventions
03/01/2009 - 02/28/2011 (PI)

11/08/2006 - 11/07/2009 (PI)
University of Rochester Dept of Defense


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Frank S, Testa CM, Stamler D, Kayson E, Davis C, Edmondson MC, Kinel S, Leavitt B, Oakes D, O'Neill C, Vaughan C, Goldstein J, Herzog M, Snively V, Whaley J, Wong C, Suter G, Jankovic J, Jimenez-Shahed J, Hunter C, Claassen DO, Roman OC, Sung V, Smith J, Janicki S, Clouse R, Saint-Hilaire M, Hohler A, Turpin D, James RC, Rodriguez R, Rizer K, Anderson KE, Heller H, Carlson A, Criswell S, Racette BA, Revilla FJ, Nucifora F, Margolis RL, Ong M, Mendis T, Mendis N, Singer C, Quesada M, Paulsen JS, Brashers-Krug T, Miller A, Kerr J, Dubinsky RM, Gray C, Factor SA, Sperin E, Molho E, Eglow M, Evans S, Kumar R, Reeves C, Samii A, Chouinard S, Beland M, Scott BL, Hickey PT, Esmail S, Fung WL, Gibbons C, Qi L, Colcher A, Hackmyer C, McGarry A, Klos K, Gudesblatt M, Fafard L, Graffitti L, Schneider DP, Dhall R, Wojcieszek JM, LaFaver K, Duker A, Neefus E, Wilson-Perez H, Shprecher D, Wall P, Blindauer KA, Wheeler L, Boyd JT, Houston E, Farbman ES, Agarwal P, Eberly SW, Watts A, Tariot PN, Feigin A, Evans S, Beck C, Orme C, Edicola J, Christopher E. Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial. JAMA. 2016 Jul 5; 316(1):40-50.View Related Profiles. PMID: 27380342; DOI: 10.1001/jama.2016.8655;
  2. Kang UJ, Goldman JG, Alcalay RN, Xie T, Tuite P, Henchcliffe C, Hogarth P, Amara AW, Frank S, Rudolph A, Casaceli C, Andrews H, Gwinn K, Sutherland M, Kopil C, Vincent L, Frasier M. The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort. Mov Disord. 2016 Jun; 31(6):924-32. PMID: 27113479; PMCID: PMC5021110; DOI: 10.1002/mds.26613;
  3. Hoss AG, Lagomarsino VN, Frank S, Hadzi TC, Myers RH, Latourelle JC. Study of plasma-derived miRNAs mimic differences in Huntington's disease brain. Mov Disord. 2015 Dec; 30(14):1961-4.View Related Profiles. PMID: 26573701; PMCID: PMC4715548; DOI: 10.1002/mds.26457;
  4. Zuzuárregui JR, Frank SA. Progressive Ataxia and Palatal Tremor. JAMA Neurol. 2015 Oct; 72(10):1195. PMID: 26258499; DOI: 10.1001/jamaneurol.2015.1114;
  5. Desalermos AP, Frank S, Farraye FA. Recurrent Bell's palsy in a patient with Crohn's disease on methotrexate. J Clin Gastroenterol. 2014 Aug; 48(7):651-2.View Related Profiles. PMID: 24492402; DOI: 10.1097/MCG.0000000000000079;
  6. Kim SY, De Vries R, Parnami S, Wilson R, Kim HM, Frank S, Holloway RG, Kieburtz K. Are therapeutic motivation and having one's own doctor as researcher sources of therapeutic misconception? J Med Ethics. 2015 May; 41(5):391-7. PMID: 24855070; PMCID: PMC4241180; DOI: 10.1136/medethics-2013-101987;
  7. Frank S. Treatment of Huntington's disease. Neurotherapeutics. 2014 Jan; 11(1):153-60. PMID: 24366610; PMCID: PMC3899480; DOI: 10.1007/s13311-013-0244-z;
  8. Kleinman M, Frank S. Epidemiology and Clinical Diagnosis of Parkinson Disease. PET Clin. 2013 Oct; 8(4):447-58. PMID: 27156472; DOI: 10.1016/j.cpet.2013.08.005;
  9. Ramos EM, Latourelle JC, Gillis T, Mysore JS, Squitieri F, Di Pardo A, Di Donato S, Gellera C, Hayden MR, Morrison PJ, Nance M, Ross CA, Margolis RL, Gomez-Tortosa E, Ayuso C, Suchowersky O, Trent RJ, McCusker E, Novelletto A, Frontali M, Jones R, Ashizawa T, Frank S, Saint-Hilaire MH, Hersch SM, Rosas HD, Lucente D, Harrison MB, Zanko A, Abramson RK, Marder K, Gusella JF, Lee JM, Alonso I, Sequeiros J, Myers RH, Macdonald ME. Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset. Neurogenetics. 2013 Nov; 14(3-4):173-9.View Related Profiles. PMID: 23644918; PMCID: PMC3825533; DOI: 10.1007/s10048-013-0364-y;
  10. Wilkenfeld AJ, Frank SA, McCarthy DC. Botulinum toxin for painful spasms from focal seizures: theoretical considerations and case report. Neurologist. 2013 Jan; 19(1):15-6. PMID: 23269101; DOI: 10.1097/NRL.0b013e31827aa7ab;
Showing 10 of 41 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Career Mentor
  • Co-Mentor or Peer Mentor
  • Education Mentor
  • Work / Life Integration Mentor
Contact for Mentoring: